Alyeska Investment Group »

Regulus Therapeutics shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.7M 938k 2.86

More positions owned by Alyeska Investment Group

Oracle Corporation (ORCL)
Alphabet Cap Stk Cl A (GOOGL)
Twilio Cl A Call Option (TWLO)
Ulta Salon, Cosmetics & Fragrance (ULTA)
Take-Two Interactive Software (TTWO)
Wal-Mart Stores (WMT)
Broadcom (AVGO)
Astrazeneca Sponsored Adr (AZN)
Adobe Systems Incorporated (ADBE)
Burlington Stores (BURL)
3M Company (MMM)
Lauder Estee Cos Cl A (EL)
Dollar General (DG)
Amazon (AMZN)
Dell Technologies CL C (DELL)

View all positions for Alyeska Investment Group

Top funds holding Regulus Therapeutics

RA Capital Management
Vivo Capital
Federated Investors
Adage Capital Partners GP
FMR
Millennium Management
Soleus Capital Management
CVI Holdings
DAFNA Capital Management
Alyeska Investment Group
Vanguard Group
Monashee Investment Management
Hudson Bay Capital Management
Polar Securities
Exome Asset Management

View all funds holding Regulus Therapeutics